Difference between revisions of "NM Coordinating Committee"

From QIBA Wiki
Jump to navigation Jump to search
m
Line 13: Line 13:
 
:* Preparing/Reviewing and Prioritizing groundwork funding proposals for submission to the Steering Committee
 
:* Preparing/Reviewing and Prioritizing groundwork funding proposals for submission to the Steering Committee
 
:* Approving for publication Biomarker Profiles developed by the NM Biomarker Committees
 
:* Approving for publication Biomarker Profiles developed by the NM Biomarker Committees
::* [[FDG-PET_Biomarker_Ctte]]
+
::*[[FDG-PET_Biomarker_Ctte]]
 
::* [[PET_Amyloid_Biomarker_Ctte]]
 
::* [[PET_Amyloid_Biomarker_Ctte]]
 
::* [[SPECT_Biomarker_Ctte]]
 
::* [[SPECT_Biomarker_Ctte]]
::* TC99m Biomarker Committee [page coming soon]
+
::* TC99m Biomarker Committee [page: https://qibawiki.rsna.org/index.php/TC99m_Biomarker_Committee]
 
::* I-123 Biomarker Committee [page coming soon]
 
::* I-123 Biomarker Committee [page coming soon]
  

Revision as of 22:53, 17 May 2022

Co-Chairs: Robert deKemp, PhD; Nathan Christopher Hall, MD, PhD; Anne Smith, PhD
RSNA Staff Support: Julie Lisiecki


Scope

The NM Coordinating Committee is responsible for:

  • Monitoring and coordinating the activities of NM Biomarker Committees
  • Considering and proposing new candidate Biomarker Committees to the Steering Committee
  • Preparing/Reviewing and Prioritizing groundwork funding proposals for submission to the Steering Committee
  • Approving for publication Biomarker Profiles developed by the NM Biomarker Committees

Meetings

  • Zoom calls are held Quarterly. Please contact RSNA Staff for details.